通过辅助使用具有三维计算机辅助分析功能的广域跨上皮样本(WATS),提高巴雷特食管和食管发育异常的检测率。
Increased detection of Barrett's esophagus and esophageal dysplasia with adjunctive use of wide-area transepithelial sample with three-dimensional computer-assisted analysis (WATS).
作者信息
Gross Seth A, Smith Michael S, Kaul Vivek
机构信息
NYU School of Medicine, Gastroenterology, New York, NY, USA.
Temple University School of Medicine, Gastroenterology, Philadelphia, PA, USA.
出版信息
United European Gastroenterol J. 2018 May;6(4):529-535. doi: 10.1177/2050640617746298. Epub 2017 Nov 28.
BACKGROUND
Barrett's esophagus (BE) and esophageal dysplasia (ED) are frequently missed during screening and surveillance esophagoscopy because of sampling error associated with four-quadrant random forceps biopsy (FB).
AIM
The aim of this article is to determine if wide-area transepithelial sampling with three-dimensional computer-assisted analysis (WATS) used adjunctively with FB can increase the detection of BE and ED.
METHODS
In this multicenter prospective trial, patients screened for suspected BE and those with known BE undergoing surveillance were enrolled. Patients at 25 community-based practices underwent WATS adjunctively to targeted FB and random four-quadrant FB.
RESULTS
Of 4203 patients, 594 were diagnosed with BE by FB alone, and 493 additional cases were detected by adding WATS, increasing the overall detection of BE by 83% (493/594, 95% CI 74%-93%). Low-grade dysplasia (LGD) was diagnosed in 26 patients by FB alone, and 23 additional cases were detected by adding WATS, increasing the detection of LGD by 88.5% (23/26, 95% CI 48%-160%).
CONCLUSIONS
Adjunctive use of WATS to FB significantly improves the detection of both BE and ED. Sampling error, an inherent limitation associated with screening and surveillance, can be improved with WATS allowing better informed decisions to be made about the management and subsequent treatment of these patients.
背景
由于与四象限随机钳取活检(FB)相关的取样误差,在筛查和监测性食管镜检查期间,巴雷特食管(BE)和食管发育异常(ED)经常被漏诊。
目的
本文旨在确定三维计算机辅助分析的广域经上皮取样(WATS)与FB联合使用是否能提高BE和ED的检出率。
方法
在这项多中心前瞻性试验中,纳入了因疑似BE而接受筛查的患者以及已知BE且正在接受监测的患者。25家社区医疗机构的患者在接受靶向FB和随机四象限FB的同时接受了WATS。
结果
在4203例患者中,仅通过FB诊断出594例BE,通过增加WATS又检测出493例,使BE的总体检出率提高了83%(493/594,95%CI 74%-93%)。仅通过FB诊断出26例低级别发育异常(LGD),通过增加WATS又检测出23例,使LGD的检出率提高了88.5%(23/26,95%CI 48%-160%)。
结论
WATS与FB联合使用可显著提高BE和ED的检出率。取样误差是筛查和监测中固有的局限性,WATS可改善这一问题,从而能对这些患者的管理和后续治疗做出更明智的决策。